Although our study indicated that UBE2C played the role in cancer stemness through regulating several cancer stemness markers including ALDH1A2, CD44, CD166 and EpCAM in oral cancer, their detailed molecular mechanisms for cancer stemness are still largely unresolved, which require further work to elucidate. The gene discussed is CD44; the disease is cancer.